Skip to main content

Open Access 11.05.2024 | Original Article

Seasonal variation in D2/3 dopamine receptor availability in the human brain

verfasst von: Lihua Sun, Tuulia Malén, Jouni Tuisku, Valtteri Kaasinen, Jarmo A. Hietala, Juha Rinne, Pirjo Nuutila, Lauri Nummenmaa

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging

Abstract

Purpose

Brain functional and physiological plasticity is essential to combat dynamic environmental challenges. The rhythmic dopamine signaling pathway, which regulates emotion, reward and learning, shows seasonal patterns with higher capacity of dopamine synthesis and lower number of dopamine transporters during dark seasons. However, seasonal variation of the dopamine receptor signaling remains to be characterized.

Methods

Based on a historical database of healthy human brain [11C]raclopride PET scans (n = 291, 224 males and 67 females), we investigated the seasonal patterns of D2/3 dopamine receptor signaling. Daylength at the time of scanning was used as a predictor for brain regional non-displaceable binding of the radiotracer, while controlling for age and sex.

Results

Daylength was negatively correlated with availability of D2/3 dopamine receptors in the striatum. The largest effect was found in the left caudate, and based on the primary sample, every 4.26 h (i.e., one standard deviation) increase of daylength was associated with a mean 2.8% drop (95% CI -0.042 to -0.014) of the receptor availability.

Conclusions

Seasonally varying D2/3 receptor signaling may also underlie the seasonality of mood, feeding, and motivational processes. Our finding suggests that in future studies of brain dopamine signaling, especially in high-latitude regions, the effect of seasonality should be considered.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00259-024-06715-9.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Brain functional and physiological plasticity is essential to combat dynamic environmental challenges, for survival and the wellbeing. This includes the potential seasonal patterns of dopamine signaling. For instance, in vivo imaging data in both healthy subjects [1] and patients [2] show increase of striatal dopamine synthesis in fall and winter. Dopamine transporter binding in the left caudate is lowered during dark seasons [3]. Also, preclinical studies suggest that longer photoperiod stimulates nucleus accumbens dopamine release in female mice [4]. Dopamine signaling plays an important role in seasonal breeding of animals [5] and, via interaction with the melatonin signaling, it affects circadian rhythms [6, 7]. Further, dopamine regulates emotion, reward, and learning that demonstrate seasonal patterns, with learning ability, attention and positive emotions all at low levels during winter months [810]. Human feeding behavior, where the brain dopamine signaling also plays a crucial role [11], similarly demonstrates seasonal patterns with increased caloric intake of fats in fall or winter [12]. Detailed knowledge on how dopamine signaling adapts to seasonal rhythms is not only essential for understanding normal molecular brain plasticity, but also crucial in understanding psychiatric conditions with seasonally varying onset and severity, such as the seasonal affective disorders.
Brain dopamine signaling is primarily relayed through the D1 family and D2 family receptors (D2Rs), where the D2Rs are found with both post- and pre-synaptic expression. This indicates an additional role of D2Rs in receptor-mediated feedback control in dopamine signaling. D2Rs are involved in both presynaptic dopamine release [13] and in regulation of dopamine synthesis [14]. For instance, D2R agonist inhibits tyrosine hydroxylase (TH) function, where TH action on L-DOPA is a rate-limiting step for dopamine synthesis [15]. Also, cAMP is known to induce expression of TH, and D2Rs inhibit the cAMP signaling [16]. Further, D2Rs may exhibit complementary interaction with dopamine transporter, so that D2Rs enhance the velocity of dopamine synaptic reuptake [17, 18]. Therefore, rhythmic D2R functions potentially direct all steps of dopamine signaling including its presynaptic synthesis and release, and extracellular clearance. Yet, potential seasonal patterns of D2R signaling remains to be characterized.
Here we analyzed a large historical dataset of healthy subjects’ brain PET scans (n = 291) measuring D2Rs (i.e., primarily the D2/3 receptors) with antagonist radioligand [11C]raclopride. We focused on the striatal and thalamic regions where this receptor is highly expressed and can be reliably measured with the used radioligand [19, 20]. Daylength was used as a regressor to predict the regional D2R availability, and data were analyzed separately for left and right hemispheres. Prior findings show that dark seasons are associated with enhanced dopamine synthetic ability [1, 2] and also reduced amount of dopamine transporters [3]. This may indicate reduced amount of extracellular dopamine, despite of increased synthesis, and enhanced presynaptic control of dopamine release. Therefore, considering the autoreceptor role of D2Rs in a feedback control, we hypothesized short daylength to be associated with increased striatal D2R availability, Fig. 1. A preprint version of the manuscript was originally reposited to bioRxiv.

Methods

Data

The data were 291 baseline [11C]raclopride scans from healthy control subjects (224 males and 67 females; age 19–81 years) collected at Turku PET Centre between 2004 and 2018. Distribution of local daylength at the time of the scan and age are illustrated in Fig. 2. For each subject, daylength was calculated as the daytime plus civil twilight on the day when the PET image was acquired, based on geographic location of the Turku PET Center (Turku, Finland; latitude = 60.4518; longitude = 22.2666), as previously [21].

PET data acquisition and image processing

Antagonist radioligand [11C]raclopride binds to D2Rs, allowing reliable quantification of striatal and thalamic D2R availability [22]. Detailed information regarding technical properties of scanners and tracer injection information is found in supplementary Table S1 & S2. We included the following regions of interest (ROIs) as delineated based on the AAL atlas [23]: nucleus accumbens, caudate nucleus (caudate), putamen and thalamus, which were separately analyzed for left and right hemispheres.
Preprocessing was done using the Magia toolbox [24]. Tracer binding was quantified using the outcome measure binding potential (BPND), which is the ratio of specific binding to non-displaceable binding in tissue [25]. BPND was estimated using a simplified reference tissue model (SRTM) [26] with cerebellar gray matter as the reference region. Acquisition length was harmonized by including first 52 min from each scan [20], independently of scan duration.

Statistical analysis

Data were analyzed using linear mixed effects regression with the R statistical software (version 4.3.0) and the lme4 package. Because ageing influences D2R availability [2729], primary analysis was based on subjects younger than 40 years old (primary analysis, n = 227). Findings based on the whole sample (n = 291) are presented in the supplementary data.
D2R BPND was modelled separately for each region of interest using fixed factors including daylength at scanning, age and sex; scanner types were used as the random intercept. D2R BPND were log-transformed, while daylength and age were standardized in the statistical models. Because BMI is only weakly associated with BPND [29] and a large portion of the subjects lacked BMI data, it was excluded from the statistical models.

Voxel-level analysis

The data were analyzed at the voxel level using SPM12 (Wellcome Trust Center for Imaging, London, UK, http://​www.​fil.​ion.​ucl.​ac.​uk/​spm). The normalized BPND images were entered into general linear models, where they were predicted with daylength. Age, sex and scanner types were entered into the models as nuisance covariates. Because [11C]raclopride binds selectively only in striatum and thalamus, the analysis was restricted to the high-binding sites by creating a single mask covering these regions (caudate, putamen, nucleus accumbens and thalamus). Statistical threshold was set at p < 0.05, FDR-corrected at cluster level.

Results

Regional analysis in the primary sample

The primary sample (n = 227) included 195 males and 32 females. The mean age was 25.6 y (SD = 4.87 y, range = 18.82–39.47 y) and average daylength exposure was 13.61 h (SD = 4.26 h, range = 7.7–23.25 h). More detailed information of the primary sample is found in supplementary Table S3.
Data revealed that daylength was linearly and negatively associated with regional D2R availability (BPND) in most regions (Table 1; Fig. 3& Fig. 4). Age was negatively associated with D2R BPND, and male subjects had lower D2R BPND (Fig. 3) than females. Information of the full sample and the corresponding findings are found in supplementary Table S4 & S5.
Table 1
Effect of daylength on regional D2R BPND in the brain (uncorrected for multiple comparison)
Hemisphere
Region
Beta
95% CI
t
p
Left
Caudate
-0.028
-0.042, -0.014
-3.86
0.00015***
Right
Caudate
-0.018
-0.032, -0.0033
-2.41
0.017*
Left
Putamen
-0.013
-0.025, -0.001
-2.11
0.036*
Right
Putamen
-0.012
-0.024, -0.000006
-1.95
0.053*
Left
NACC
-0.019
-0.036, -0.0024
-2.23
0.027*
Right
NACC
-0.016
-0.033, 0.0015
-1.78
0.077
Left
Thalamus
-0.016
-0.039, 0.0056
-1.46
0.15
Right
Thalamus
-0.0065
-0.028, 0.015
-0.60
0.55
We compared the effect size (i.e., 95% CI) between daylength, age and sex, Fig. 3. In the primary sample, every 4.26 h (i.e., one standard deviation) increase of daylength was associated with a mean 2.8% drop of D2R BPND in the left caudate. In the same region, every 4.87 y (i.e., one standard deviation) increase of age was associated with a mean 3.3% drop of D2R BPND. Corresponding results based on the full sample are found in Supplementary Figure S1.

Voxel-level analysis in the primary sample

We next run a complementary voxel-level analysis for the high-binding regions (striatum and thalamus). Similar as in the ROI analysis, daylength was found to be a significant predictor for striatal D2R BPND, Fig. 5.

Effect of daylength in the whole sample

Considering the impact of ageing on dopamine signaling [2729], there is always a tradeoff between sample size and the allowed maximum age. In addition to a primary sample analysis, we also investigated how the effect of daylength survived a stepwise minimization of sample in accord to the allowed maximum age.
We analysed the effect of daylength in different groups where the whole sample was divided into 7 groups in accord to the allowed maximum age, Table 2. Results showed that the effect of daylength of D2R BPND retained across different groups, especially in the left caudate (Fig. 6 and Supplementary Figure S2). This accords with previous findings that highlight the importance of the left caudate region, regarding both seasonal variation of dopamine transporter signaling [3] and dopamine-relevant etiology in seasonal affective disorders [30].
Table 2
Daylength and age across groups defined by maximum age. Information of the primary sample are highlighted in bold
Groups
Number of subjects
(female)
Age (y)
 
Daylength
mean
SD
 
mean
SD
min
max
All
291(67)
31.65
13.43
 
13.84
4.43
7.70
23.28
< 60 y
279(61)
30.07
11.19
 
13.73
4.40
7.70
23.28
< 50 y
252(43)
27.38
7.92
 
13.66
4.35
7.70
23.25
< 40 y
227(32)
25.26
4.87
 
13.61
4.26
7.70
23.25
< 35 y
213(27)
24.45
3.79
 
13.53
4.20
7.70
23.25
< 30 y
188(23)
23.41
2.6
 
13.44
4.17
7.70
23.25
< 25 y
135(10)
22.07
1.57
 
13.14
4.10
7.70
23.25

Discussion

Our main finding was that daylength modulated in vivo brain D2R availability in healthy humans. Specifically, striatal D2R availability was elevated in autumn-winter time when the days are short and lowered during the spring-summer time when the days are long. This finding is based on, to our knowledge, the largest database of healthy human D2R PET images. The pattern of seasonal change was the most consistent in the left caudate, aligning with previous studies showing that dark seasons are associated with lowered amount of dopamine transporter in the left caudate [3]. Also, patients with seasonal affective disorder (SAD) show lowered dopamine transporter binding in the left caudate [30], possibly indicating that dopamine signaling in the left caudate is linked with seasonal onsets of depression symptoms. The effect was also large: one standard deviation of daylength change (i.e., around 4 h) was associated with equal magnitude of D2R binding changes as 2–5 years of ageing in the left caudate. The effect of daylength on D2R was comparable in the datasets with only young and middle-aged adults as well as in the data with full age range. This suggests that the impact of daylength is consistent across age cohorts. Altogether these data suggest that in future studies of D2R binding, especially in high-latitude regions, the effect of seasonality should be considered as it may confound the primary results.
Seasonality in the human brain physiology and particularly neurotransmission remains poorly characterized [31, 32]. There is evidence showing that dark seasons are associated with lowered postsynaptic serotonin receptor availability [33, 34] and probably increased serotonin transporter binding [35, 36]. Clinical in vivo data also indicates a light-sensitive fluctuation in levels of cerebral monoamine oxidase A, an enzyme that degrades neurotransmitters including serotonin and dopamine [37]. Similarly, studies on neuropeptide signaling suggest that the endogenous opioid signaling responds to seasonal rhythms [21, 38]. The present results on dopamine receptor signaling further highlight the brain neurotransmission mechanism on seasonal patterns of cognitive and affective functions.
Previous studies of dopamine signaling using 18F-DOPA PET have found an increase in presynaptic synthesis of dopamine during autumn and winter [1, 2]. This complements our study showing increased D2R availability during dark season, signifying that this increase most probably indicates enhanced presynaptic control of dopamine release. D2Rs are known as autoreceptors that modulate the presynaptic synthesis of dopamine [1416], and the increased D2R signaling is to encounter the increased dopamine synthetic capability. This is also supported by findings that the dopamine transporter binding in the left caudate is lower during dark seasons [3], as D2Rs may not only restrict dopamine release but also enhance transporter functions [17, 18]. Besides, the increased availability of D2Rs may further be mirrored by increased melatonin release during dark seasons, since melatonin is known to inhibit presynaptic dopamine release [39, 40].
However, one study using single photon emission computed tomography with [123I]iodo-benzamide to measure dopamine D2/D3 receptor availability, shows that shorter rather than longer sunlight exposure is associated with reduced amounts of striatal receptors [41]. This study used data from low latitude regions where variation of daylength across seasons is small (i.e., around 4 h between longest and shortest days in local region), and the subjects are divided into two groups where unbalanced sex and smoker effects may also complicate the interpretation of the finding. Further, reference tissue modeling of PET data in the study used the frontal lobe as a reference region and this may also compromise their conclusions.
The striatum is a key node for reward responses [42] and energy supply in the caudate may directly affect the feeling of satiation or hunger [43]. Given the role of striatal dopamine signaling in feeding behavior, enhanced D2R signaling in dark seasons may induce overeating [12]. Also, while this effect was observed in both hemispheres, larger effect in the left caudate may hint at a season-dependent lateral difference in the normal brain function, mirroring findings that patients with SADs show state-dependent lateral differences of EEG power and coherence during depressive episodes and following light-induced and summer remission [44]. Only a few studies have focused on the role of dopamine signaling in SADs [30], and therefore, it is challenging to interpret how malfunction in a signal component of this signaling pathway predispose specific symptom such as the overeating character of SAD. Seasonal rhythms profoundly impact mood, with negative affect such as depression, anger, and hostility at lowest rate during the summer [45], whereas symptoms of SAD peak during the winter months [46]. These changes are probably mediated by slow phasic changes in a variety neuroreceptor systems including the dopamine receptor signaling.

Limitations

The [11C]raclopride BPND in a baseline condition is proportional to D2R density, but the exact contributions of D2R density, receptor affinity, and baseline occupancy by endogenous dopamine cannot be assessed in a single measurement. The study was based on historical data, where each subject was imaged only once; quasi-experimental design (i.e., natural changes in daylight) was used as longitudinal multi-scan studies would yield a significant radiation load, as in some studies [47, 48]. The data were sampled from different projects and scanners; partial volume effect might contribute to the results causing spillover effects from the adjacent striatal regions, particularly concerning scanners with lower spatial resolutions. Potential scanner-related biases were, however, accounted for in the analyses. Daylength was regarded as a noise-free estimate of local seasons. Day-to-day variance of sunlight exposure and contribution of other seasonal factors (e.g., atmospheric pressure, temperature), however, were not investigated. Longer daylengths in certain seasons generally correspond to more daylight hours, providing people with additional opportunities for outdoor activities and exposure to sunlight. Further, the database was compiled from historical scans and relevant behavioral and self-report measures, such as mood and eating habits, were not systematically collected. Finally, the present findings from high-latitude regions may not generalize to regions with lower latitudes, considering the large magnitude of local photoperiodic variation.

Conclusions

We conclude that striatal D2R availability is increased during dark seasons. While the exact mechanisms and subsequent impacts of this seasonal pattern of receptor signaling cannot be resolved in this cross-sectional study, our study nevertheless reveals brains’ physiological adaption to seasons at the level of single neurotransmitter system. Considering the important role of striatal dopamine signaling in reward-related behaviors, elevated D2Rs may contribute to the elevated food seeking during dark seasons.

Declarations

Competing interests

The authors declare no competing interests.

Ethics approval

Under the Finnish legislation, no ethical approval is required for register-based studies.
The study does not require consents of participants as it is based on registered data.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Eisenberg DP, Kohn PD, Baller EB, Bronstein JA, Masdeu JC, Berman KF. Seasonal effects on human striatal presynaptic dopamine synthesis. J Neurosci. 2010;30:14691–4.CrossRefPubMedPubMedCentral Eisenberg DP, Kohn PD, Baller EB, Bronstein JA, Masdeu JC, Berman KF. Seasonal effects on human striatal presynaptic dopamine synthesis. J Neurosci. 2010;30:14691–4.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Kaasinen V, Jokinen P, Joutsa J, Eskola O, Rinne JO. Seasonality of striatal dopamine synthesis capacity in Parkinson’s disease. Neurosci Lett. 2012;530:80–4.CrossRefPubMed Kaasinen V, Jokinen P, Joutsa J, Eskola O, Rinne JO. Seasonality of striatal dopamine synthesis capacity in Parkinson’s disease. Neurosci Lett. 2012;530:80–4.CrossRefPubMed
3.
Zurück zum Zitat Booij J, Tellier SP, Seibyl J, Vriend C. Dopamine transporter availability in early parkinson’s disease is dependent on sunlight exposure. Mov Disord. 2023;38:2131–5. Booij J, Tellier SP, Seibyl J, Vriend C. Dopamine transporter availability in early parkinson’s disease is dependent on sunlight exposure. Mov Disord. 2023;38:2131–5.
4.
Zurück zum Zitat Jameson AN, Siemann JK, Melchior J, Calipari ES, McMahon DG, Grueter BA. Photoperiod impacts nucleus accumbens dopamine dynamics. eNeuro. 2023;10. Jameson AN, Siemann JK, Melchior J, Calipari ES, McMahon DG, Grueter BA. Photoperiod impacts nucleus accumbens dopamine dynamics. eNeuro. 2023;10.
5.
Zurück zum Zitat Gerlach T, Aurich JE. Regulation of seasonal reproductive activity in the stallion, ram and hamster. Anim Reprod Sci. 2000;58:197–213.CrossRefPubMed Gerlach T, Aurich JE. Regulation of seasonal reproductive activity in the stallion, ram and hamster. Anim Reprod Sci. 2000;58:197–213.CrossRefPubMed
6.
Zurück zum Zitat El Halawani ME, Kang SW, Leclerc B, Kosonsiriluk S, Chaiseha Y. Dopamine–melatonin neurons in the avian hypothalamus and their role as photoperiodic clocks. Gen Comp Endocrinol. 2009;163:123–7.CrossRefPubMed El Halawani ME, Kang SW, Leclerc B, Kosonsiriluk S, Chaiseha Y. Dopamine–melatonin neurons in the avian hypothalamus and their role as photoperiodic clocks. Gen Comp Endocrinol. 2009;163:123–7.CrossRefPubMed
7.
Zurück zum Zitat Cahill GM, Besharse JC. Resetting the circadian clock in cultured Xenopus eyecups: regulation of retinal melatonin rhythms by light and D2 dopamine receptors. J Neurosci. 1991;11:2959–71.CrossRefPubMedPubMedCentral Cahill GM, Besharse JC. Resetting the circadian clock in cultured Xenopus eyecups: regulation of retinal melatonin rhythms by light and D2 dopamine receptors. J Neurosci. 1991;11:2959–71.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mooldijk SS, Licher S, Vernooij MW, Ikram MK, Ikram MA. Seasonality of cognitive function in the general population: the rotterdam study. Geroscience. 2022;44:281–91. Mooldijk SS, Licher S, Vernooij MW, Ikram MK, Ikram MA. Seasonality of cognitive function in the general population: the rotterdam study. Geroscience. 2022;44:281–91.
9.
Zurück zum Zitat Meyer C, Muto V, Jaspar M, Kusse C, Lambot E, Chellappa SL, et al. Seasonality in human cognitive brain responses. Proc Natl Acad Sci U S A. 2016;113:3066–71.CrossRefPubMedPubMedCentral Meyer C, Muto V, Jaspar M, Kusse C, Lambot E, Chellappa SL, et al. Seasonality in human cognitive brain responses. Proc Natl Acad Sci U S A. 2016;113:3066–71.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Golder SA, Macy MW. Diurnal and seasonal mood vary with work, sleep, and daylength across diverse cultures. Science. 2011;333:1878–81.CrossRefPubMed Golder SA, Macy MW. Diurnal and seasonal mood vary with work, sleep, and daylength across diverse cultures. Science. 2011;333:1878–81.CrossRefPubMed
11.
Zurück zum Zitat Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage. 2003;19:1709–15.CrossRefPubMed Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage. 2003;19:1709–15.CrossRefPubMed
12.
Zurück zum Zitat Shahar DR, Froom P, Harari G, Yerushalmi N, Lubin F, Kristal-Boneh E. Changes in dietary intake account for seasonal changes in cardiovascular disease risk factors. Eur J Clin Nutr. 1999;53:395–400.CrossRefPubMed Shahar DR, Froom P, Harari G, Yerushalmi N, Lubin F, Kristal-Boneh E. Changes in dietary intake account for seasonal changes in cardiovascular disease risk factors. Eur J Clin Nutr. 1999;53:395–400.CrossRefPubMed
15.
Zurück zum Zitat Pothos EN, Przedborski S, Davila V, Schmitz Y, Sulzer D. D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci. 1998;18:5575–85.CrossRefPubMedPubMedCentral Pothos EN, Przedborski S, Davila V, Schmitz Y, Sulzer D. D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci. 1998;18:5575–85.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Chen X, Xu L, Radcliffe P, Sun B, Tank AW. Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons. Mol Pharmacol. 2008;73:1816–28.CrossRefPubMed Chen X, Xu L, Radcliffe P, Sun B, Tank AW. Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons. Mol Pharmacol. 2008;73:1816–28.CrossRefPubMed
17.
18.
Zurück zum Zitat Wu Q, Reith ME, Walker QD, Kuhn CM, Carroll FI, Garris PA. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci. 2002;22:6272–81.CrossRefPubMedPubMedCentral Wu Q, Reith ME, Walker QD, Kuhn CM, Carroll FI, Garris PA. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci. 2002;22:6272–81.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Freiburghaus T, Svensson JE, Matheson GJ, Plavén-Sigray P, Lundberg J, Farde L, et al. Low convergent validity of [11 C] raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [11 C] FLB 457. NeuroImage. 2021;226:117523.CrossRefPubMed Freiburghaus T, Svensson JE, Matheson GJ, Plavén-Sigray P, Lundberg J, Farde L, et al. Low convergent validity of [11 C] raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [11 C] FLB 457. NeuroImage. 2021;226:117523.CrossRefPubMed
20.
Zurück zum Zitat Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, et al. Measurement of striatal and thalamic dopamine D2 receptor binding with 11 C-raclopride. Nucl Med Commun. 2003;24:1207–14.CrossRefPubMed Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, et al. Measurement of striatal and thalamic dopamine D2 receptor binding with 11 C-raclopride. Nucl Med Commun. 2003;24:1207–14.CrossRefPubMed
21.
Zurück zum Zitat Sun L, Tang J, Liljenback H, Honkaniemi A, Virta J, Isojarvi J, et al. Seasonal Variation in the Brain Mu-Opioid receptor availability. J Neurosci. 2021;41:1265–73.CrossRefPubMedPubMedCentral Sun L, Tang J, Liljenback H, Honkaniemi A, Virta J, Isojarvi J, et al. Seasonal Variation in the Brain Mu-Opioid receptor availability. J Neurosci. 2021;41:1265–73.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedstrom CG, et al. Substituted benzamides as ligands for visualization of dopamine receptor-binding in the human-brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 1985;82:3863–7. Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedstrom CG, et al. Substituted benzamides as ligands for visualization of dopamine receptor-binding in the human-brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 1985;82:3863–7.
23.
Zurück zum Zitat Rolls ET, Joliot M, Tzourio-Mazoyer N. Implementation of a new parcellation of the orbitofrontal cortex in the automated anatomical labeling atlas. NeuroImage. 2015;122:1–5.CrossRefPubMed Rolls ET, Joliot M, Tzourio-Mazoyer N. Implementation of a new parcellation of the orbitofrontal cortex in the automated anatomical labeling atlas. NeuroImage. 2015;122:1–5.CrossRefPubMed
24.
Zurück zum Zitat Karjalainen T, Tuisku J, Santavirta S, Kantonen T, Bucci M, Tuominen L, et al. Magia: Robust Automated Image Processing and Kinetic modeling toolbox for PET neuroinformatics. Front Neuroinform. 2020;14:3.CrossRefPubMedPubMedCentral Karjalainen T, Tuisku J, Santavirta S, Kantonen T, Bucci M, Tuominen L, et al. Magia: Robust Automated Image Processing and Kinetic modeling toolbox for PET neuroinformatics. Front Neuroinform. 2020;14:3.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metabolism. 2007;27:1533–9.CrossRef Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metabolism. 2007;27:1533–9.CrossRef
26.
Zurück zum Zitat Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage. 1996;4:153–8.CrossRefPubMed Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage. 1996;4:153–8.CrossRefPubMed
27.
Zurück zum Zitat Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309–15.CrossRefPubMed Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309–15.CrossRefPubMed
29.
Zurück zum Zitat Malén T, Karjalainen T, Isojärvi J, Vehtari A, Bürkner P-C, Putkinen V, et al. Atlas of type 2 dopamine receptors in the human brain: age and sex dependent variability in a large PET cohort. NeuroImage. 2022;255:119149.CrossRefPubMed Malén T, Karjalainen T, Isojärvi J, Vehtari A, Bürkner P-C, Putkinen V, et al. Atlas of type 2 dopamine receptors in the human brain: age and sex dependent variability in a large PET cohort. NeuroImage. 2022;255:119149.CrossRefPubMed
30.
Zurück zum Zitat Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med. 2001;31:1467–73.CrossRefPubMed Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med. 2001;31:1467–73.CrossRefPubMed
32.
Zurück zum Zitat Levitan RD. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci. 2007;9:315–24. Levitan RD. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci. 2007;9:315–24.
33.
Zurück zum Zitat Matheson GJ, Schain M, Almeida R, Lundberg J, Cselenyi Z, Borg J, et al. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. NeuroImage. 2015;112:225–31.CrossRefPubMed Matheson GJ, Schain M, Almeida R, Lundberg J, Cselenyi Z, Borg J, et al. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. NeuroImage. 2015;112:225–31.CrossRefPubMed
34.
Zurück zum Zitat Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, et al. Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain. World J Biol Psychiatry. 2012;13:413–22.CrossRefPubMed Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, et al. Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain. World J Biol Psychiatry. 2012;13:413–22.CrossRefPubMed
35.
Zurück zum Zitat Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry. 2008;65:1072–8.CrossRefPubMed Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry. 2008;65:1072–8.CrossRefPubMed
36.
Zurück zum Zitat Koskela A, Kauppinen T, Keski-Rahkonen A, Sihvola E, Kaprio J, Rissanen A, et al. Brain serotonin transporter binding of [123I] ADAM: within‐subject variation between summer and Winter Data. Chronobiol Int. 2008;25:657–65.CrossRefPubMed Koskela A, Kauppinen T, Keski-Rahkonen A, Sihvola E, Kaprio J, Rissanen A, et al. Brain serotonin transporter binding of [123I] ADAM: within‐subject variation between summer and Winter Data. Chronobiol Int. 2008;25:657–65.CrossRefPubMed
37.
Zurück zum Zitat Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Transl Psychiatry. 2018;8:198.CrossRefPubMedPubMedCentral Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Transl Psychiatry. 2018;8:198.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Sun L, Aarnio R, Herre EA, Karna S, Palani S, Virtanen H, et al. [(11)C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue. Eur J Nucl Med Mol Imaging. 2022.CrossRefPubMedPubMedCentral Sun L, Aarnio R, Herre EA, Karna S, Palani S, Virtanen H, et al. [(11)C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue. Eur J Nucl Med Mol Imaging. 2022.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Wehr TA. The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab. 1991;73:1276–80.CrossRefPubMed Wehr TA. The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab. 1991;73:1276–80.CrossRefPubMed
40.
Zurück zum Zitat Zisapel N. Melatonin–dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 2001;21:605–16.CrossRefPubMed Zisapel N. Melatonin–dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 2001;21:605–16.CrossRefPubMed
41.
Zurück zum Zitat Tsai H-Y, Chen KC, Yang YK, Chen PS, Yeh TL, Chiu NT, et al. Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:107–10.CrossRefPubMed Tsai H-Y, Chen KC, Yang YK, Chen PS, Yeh TL, Chiu NT, et al. Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:107–10.CrossRefPubMed
43.
Zurück zum Zitat Sun L, Laurila S, Lahesmaa M, Rebelos E, Virtanen KA, Schnabl K, et al. Secretin modulates appetite via brown adipose tissue-brain axis. Eur J Nucl Med Mol Imaging. 2023;50:1597–606.CrossRefPubMedPubMedCentral Sun L, Laurila S, Lahesmaa M, Rebelos E, Virtanen KA, Schnabl K, et al. Secretin modulates appetite via brown adipose tissue-brain axis. Eur J Nucl Med Mol Imaging. 2023;50:1597–606.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Passynkova NR, Volf NV. Seasonal affective disorder: spatial organization of EEG power and coherence in the depressive state and in light-induced and summer remission. Psychiatry Research: Neuroimaging. 2001;108:169–85.CrossRef Passynkova NR, Volf NV. Seasonal affective disorder: spatial organization of EEG power and coherence in the depressive state and in light-induced and summer remission. Psychiatry Research: Neuroimaging. 2001;108:169–85.CrossRef
45.
Zurück zum Zitat Harmatz MG, Well AD, Overtree CE, Kawamura KY, Rosal M, Ockene IS. Seasonal variation of depression and other moods: a longitudinal approach. J Biol Rhythms. 2000;15:344–50CrossRefPubMed Harmatz MG, Well AD, Overtree CE, Kawamura KY, Rosal M, Ockene IS. Seasonal variation of depression and other moods: a longitudinal approach. J Biol Rhythms. 2000;15:344–50CrossRefPubMed
46.
Zurück zum Zitat Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci. 2000;25:469.PubMedPubMedCentral Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci. 2000;25:469.PubMedPubMedCentral
47.
Zurück zum Zitat Jonasson LS, Nyberg L, Axelsson J, Kramer AF, Riklund K, Boraxbekk C-J. Higher striatal D2-receptor availability in aerobically fit older adults but non-selective intervention effects after aerobic versus resistance training. NeuroImage. 2019;202:116044.CrossRefPubMed Jonasson LS, Nyberg L, Axelsson J, Kramer AF, Riklund K, Boraxbekk C-J. Higher striatal D2-receptor availability in aerobically fit older adults but non-selective intervention effects after aerobic versus resistance training. NeuroImage. 2019;202:116044.CrossRefPubMed
48.
Zurück zum Zitat Nevalainen N, Riklund K, Andersson M, Axelsson J, Ögren M, Lövdén M, et al. COBRA: a prospective multimodal imaging study of dopamine, brain structure and function, and cognition. Brain Res. 2015;1612:83–103.CrossRefPubMed Nevalainen N, Riklund K, Andersson M, Axelsson J, Ögren M, Lövdén M, et al. COBRA: a prospective multimodal imaging study of dopamine, brain structure and function, and cognition. Brain Res. 2015;1612:83–103.CrossRefPubMed
Metadaten
Titel
Seasonal variation in D2/3 dopamine receptor availability in the human brain
verfasst von
Lihua Sun
Tuulia Malén
Jouni Tuisku
Valtteri Kaasinen
Jarmo A. Hietala
Juha Rinne
Pirjo Nuutila
Lauri Nummenmaa
Publikationsdatum
11.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-024-06715-9